Social Media Press Releases

RSS

Showing Press Releases with Tag: pipeline

10/30/2009

MedImmune to Present 4 Abstracts on RSV and Influenza at 47TH Annual IDSA Meeting

» read more
7/28/2009

FluMist(R) Begins Shipping for 2009-2010 Influenza Season

» read more
6/01/2009

HHS Awards MedImmune Contract to Manufacture Live Attenuated Nasal Spray Vaccine for Novel Influenza A (H1N1)

» read more
5/05/2009

FluMist® Shows Acceptable Safety Profile in Immunocompromised Children, According to New Findings Presented at Pediatric Academic Societies Annual Meeting

» read more
2/07/2008

MedImmune Strengthens Key Leadership Functions to Further Support Recently Expanded, Rapidly Advancing Product Portfolio

» read more
12/07/2007

AstraZeneca Presents its Global Biologics Organisation, MedImmune, at 2007 Analyst and Investor R&D Day

» read more
10/09/2007

Data from MedImmune Infectious Disease Clinical Programs Presented at European Society for Paediatric Research Annual Meeting

» read more
8/23/2007

MedImmune Celebrates Opening of New Pilot Lab at Gaithersburg Headquarters

» read more
5/24/2007

MedImmune Highlights Advances in Inflammatory Disease Pipeline With Series of Data Presentations

» read more
5/02/2007

Pediatric Academic Societies’ Annual Meeting to Feature Data Presentations Related to MedImmune Clinical Programs in Influenza, RSV and hMPV

» read more
4/23/2007

AstraZeneca to acquire MedImmune for $58 per share in a fully recommended, all-cash transaction with a total enterprise value of $15.2 billion

» read more
4/18/2007

Micromet and MedImmune Present Data From Preclinical Study of New BiTE(R) Molecule Targeting CEA

» read more
4/02/2007

MedImmune Promotes Three Leaders in Key Scientific & Medical Roles

» read more
3/16/2007

MedImmune Leases Human Genome Sciences Facility to Expand Cell Culture Influenza Vaccine Manufacturing Capabilities

» read more
2/07/2007

MedImmune Reports Financial Results For 2006

» read more